Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe

Abstract

Background The primary aim of this study was to assess the outcome of elderly intensive care unit (ICU) patients treated during the spring and autumn COVID-19 surges in Europe. Methods This was a prospective European observational study (the COVIP study) in ICU patients aged 70 years and older admitted with COVID-19 disease from March to December 2020 to 159 ICUs in 14 European countries. An electronic database was used to register a number of parameters including: SOFA score, Clinical Frailty Scale, co-morbidities, usual ICU procedures and survival at 90 days. The study was registered at ClinicalTrials.gov (NCT04321265). Results In total, 2625 patients were included, 1327 from the first and 1298 from the second surge. Median age was 74 and 75 years in surge 1 and 2, respectively. SOFA score was higher in the first surge (median 6 versus 5, p < 0.0001). The PaO2/FiO2 ratio at admission was higher during surge 1, and more patients received invasive mechanical ventilation (78% versus 68%, p < 0.0001). During the first 15 days of treatment, survival was similar during the first and the second surge. Survival was lower in the second surge after day 15 and differed after 30 days (57% vs 50%) as well as after 90 days (51% vs 40%). Conclusion An unexpected, but significant, decrease in 30-day and 90-day survival was observed during the second surge in our cohort of elderly ICU patients. The reason for this is unclear. Our main concern is whether the widespread changes in practice and treatment of COVID-19 between the two surges have contributed to this increased mortality in elderly patients. Further studies are urgently warranted to provide more evidence for current practice in elderly patients. Trial registration number NCT04321265, registered March 19th, 2020.

In-hospital mortality of older patients with COVID-19 throughout the epidemic waves in the great Paris area: a multicenter cohort study

“…Patients were included the day of admission, and followed-up until discharge, death or end of study period (15th of April 2022). Data extraction took place 10 weeks after the last patient inclusion in order to accurately collect data on mortality [ 12 ]. One hospitalization could include transfers in different acute care departments (intensive care units, acute medical wards, intermediate care units).…”

“…Due to a higher prevalence of comorbidities, loss of functional status, and an unclear benefit/risk balance of COVID-19 treatment, mortality of older patients during the Omicron wave could be higher than what has been previously published in the younger population. A prospective multicentre study on 2,625 patients aged ≥ 75 years hospitalized in intensive care units (ICU) for COVID-19 found an increased mortality rate during the second wave, comparatively with the first one, although intensivist had acquired more experience during the second wave [ 12 ]. Progress could be made in COVID-19 management in the older population.…”

Mortality Trend of Severe COVID-19 in Under-Vaccinated Population Admitted to ICU in French Amazonia

“…Many studies have described the characteristics of patients with COVID-19 [ 2 , 3 , 4 ]. They have investigated outcomes, especially among older and vulnerable populations [ 5 , 6 ]. In some studies, the mortality rate reached 60% [ 7 , 8 ] and decreased over time, mainly because of vaccination coverage [ 9 , 10 ].…”

Navigating the pandemic: A critical perspective on COVID-19 responses in Central America

“…As a result, this age group has higher case fatality rates. Individuals aged 65 years and older had the highest number of deaths in Europe in 2020 and 2021 [4]. In Canada and the United States, older patients had more admissions to intensive care units, but for shorter durations compared to other age groups.…”